These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15937873)

  • 1. Cardiac involvement in muscular dystrophies: molecular mechanisms.
    Goodwin FC; Muntoni F
    Muscle Nerve; 2005 Nov; 32(5):577-88. PubMed ID: 15937873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways.
    Jung C; Martins AS; Niggli E; Shirokova N
    Cardiovasc Res; 2008 Mar; 77(4):766-73. PubMed ID: 18056762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyopathy in muscular dystrophies.
    Muntoni F
    Curr Opin Neurol; 2003 Oct; 16(5):577-83. PubMed ID: 14501841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular etiopathogenesis of limb girdle muscular and congenital muscular dystrophies: boundaries and contiguities.
    Guglieri M; Magri F; Comi GP
    Clin Chim Acta; 2005 Nov; 361(1-2):54-79. PubMed ID: 16002060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophic heart failure blocked by membrane sealant poloxamer.
    Yasuda S; Townsend D; Michele DE; Favre EG; Day SM; Metzger JM
    Nature; 2005 Aug; 436(7053):1025-9. PubMed ID: 16025101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limb-girdle muscular dystrophy due to emerin gene mutations.
    Ura S; Hayashi YK; Goto K; Astejada MN; Murakami T; Nagato M; Ohta S; Daimon Y; Takekawa H; Hirata K; Nonaka I; Noguchi S; Nishino I
    Arch Neurol; 2007 Jul; 64(7):1038-41. PubMed ID: 17620497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cell biology of the sarcoglycan complex.
    Ozawa E; Mizuno Y; Hagiwara Y; Sasaoka T; Yoshida M
    Muscle Nerve; 2005 Nov; 32(5):563-76. PubMed ID: 15937871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoglycan subcomplex in normal and pathological human muscle fibers.
    Anastasi G; Cutroneo G; Rizzo G; Favaloro A
    Eur J Histochem; 2007; 51 Suppl 1():29-33. PubMed ID: 17703591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The childhood limb-girdle muscular dystrophies.
    Straub V; Bushby K
    Semin Pediatr Neurol; 2006 Jun; 13(2):104-14. PubMed ID: 17027860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscular dystrophies related to the cytoskeleton/nuclear envelope.
    Nowak K; McCullagh K; Poon E; Davies KE
    Novartis Found Symp; 2005; 264():98-111; discussion 112-7, 227-30. PubMed ID: 15773750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression.
    Vieira NM; Bueno CR; Brandalise V; Moraes LV; Zucconi E; Secco M; Suzuki MF; Camargo MM; Bartolini P; Brum PC; Vainzof M; Zatz M
    Stem Cells; 2008 Sep; 26(9):2391-8. PubMed ID: 18583542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A.
    Groen EJ; Charlton R; Barresi R; Anderson LV; Eagle M; Hudson J; Koref MS; Straub V; Bushby KM
    Brain; 2007 Dec; 130(Pt 12):3237-49. PubMed ID: 18055493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene.
    Nakamura A; Yoshida K; Fukushima K; Ueda H; Urasawa N; Koyama J; Yazaki Y; Yazaki M; Sakai T; Haruta S; Takeda S; Ikeda S
    J Clin Neurosci; 2008 Jul; 15(7):757-63. PubMed ID: 18261911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
    Au CG; Butler TL; Egan JR; Cooper ST; Lo HP; Compton AG; North KN; Winlaw DS
    Acta Neuropathol; 2008 Sep; 116(3):235-46. PubMed ID: 18392839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy.
    Sveen ML; Thune JJ; Køber L; Vissing J
    Arch Neurol; 2008 Sep; 65(9):1196-201. PubMed ID: 18779423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laryngeal muscles are spared in the dystrophin deficient mdx mouse.
    Thomas LB; Joseph GL; Adkins TD; Andrade FH; Stemple JC
    J Speech Lang Hear Res; 2008 Jun; 51(3):586-95. PubMed ID: 18506037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy.
    Heydemann A; McNally EM
    Trends Cardiovasc Med; 2007 Feb; 17(2):55-9. PubMed ID: 17292047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ins and outs of therapy in limb girdle muscular dystrophies.
    Danièle N; Richard I; Bartoli M
    Int J Biochem Cell Biol; 2007; 39(9):1608-24. PubMed ID: 17339125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerin and the nuclear lamina in muscle and cardiac disease.
    Holaska JM
    Circ Res; 2008 Jul; 103(1):16-23. PubMed ID: 18596264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype?
    Pizzanelli C; Mancuso M; Galli R; Choub A; Fanin M; Nascimbeni AC; Siciliano G; Murri L
    Neurol Sci; 2006 Jun; 27(2):134-6. PubMed ID: 16816913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.